Company: AEMD
Filing Date: 2025-07-25
Form Type: DRS
Source: 0001683168-25-005397
Chunk: 74

Company: AETHLON MEDICAL INC
Filing Date: 2025-07-25
Form: DRS
Chunk 74
---
 subject of the offering has been, or will be made to the public
in that Member State, other than under the following exemptions under the Prospectus Directive:

| (a) | to any legal entity which is a qualified investor as defined in the Prospectus Directive; |
| (b) | to fewer than 150 natural or legal persons (other                                         
 than qualified investors as defined in the Prospectus Directive),                         
 subject to obtaining the prior consent of the                                             
 Representatives for any such offer; or                                                    |
| (c) | in any other circumstances falling within Article 3(2) of the Prospectus Directive,       |

provided that no such offer of securities
referred to in (a) to (c) above shall result in a requirement for the Company or the placement agent to publish a prospectus
pursuant to Article 3 of the Prospectus Directive, or supplement a prospectus pursuant to Article 16 of the Prospectus Directive.

Each person located in a Member
State to whom any offer of securities is made or who receives any communication in respect of an offer of securities, or who initially
acquires any shares of our securities will be deemed to have represented, warranted, acknowledged and agreed to and with the placement
agent and the Company that (1) it is a “qualified investor” within the meaning of the law in that Member State implementing
Article 2(1)(e) of the Prospectus Directive; and (2) in the case of any shares of our securities acquired by it as a financial
intermediary as that term is used in Article 3(2) of the Prospectus Directive, the securities acquired by it in the offer have not
been acquired on behalf of, nor have they been acquired with a view to their offer or resale to, persons in any Member State other than
qualified investors, as that term is defined in the Prospectus Directive, or in circumstances in which the prior consent of the placement
agent has been given to the offer or resale; or where our securities have been acquired by it on behalf of persons in any Member State
other than qualified investors, the offer of those securities to it is not treated under the Prospectus Directive as having been made
to such persons.

| 40 |

The Company, the placement
agent and their respective affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgments and agreements.

This prospectus has been prepared
on the basis that any offer of our securities in any Member State will